Ryan Allway March 29th, 2022 News, Top News VANCOUVER, BC / ACCESSWIRE / March 29, 2022 / Franchise Global Health Inc. (“Franchise Global” or the “Company”) (TSXV: FGH) is pleased to announce that the Company’s shares will commence trading at market open today on the TSX Venture Exchange under the symbol “FGH”.... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway March 28th, 2022 News, Top News CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 28, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Medspresso™ and Liviana™ are... Read more
Ryan Allway March 28th, 2022 News, Top News TORONTO, March 28, 2022–(BUSINESS WIRE)–Hempsana Holdings Ltd. (the “Company” or “Hempsana“) a leader in the production and refinement of cannabinoids and Cannabis 2.0 products, is delighted to announce that it has entered into a contract manufacturing agreement with GAMA Corp (“GAMA“)... Read more
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer
March 28, 2022
Ryan Allway March 28th, 2022 News, Top News VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news release dated February 23, 2022, it has entered into a definitive... Read more
Ryan Allway March 28th, 2022 News, Top News TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has changed its corporate name to “CNBX Pharmaceuticals Inc.” CNBX Pharmaceuticals The Company’s new... Read more
Psychedelic Pharmaceutical Startup Ninnion Announces Formation of World Renowned Scientific Advisory Board
March 28, 2022
Ryan Allway March 28th, 2022 Psychedelics, Top News Board members include industry pioneers Dr. Rick Strassman and Dr. Charles B Nemeroff AUSTIN, TX –News Direct– Ninnion Ninnion, a clinical-stage pharmaceutical company focused on developing next-generation psychedelic therapeutics today announced the formation of its Scientific Advisory Board (SAB). The board... Read more
Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth
March 25, 2022
TORONTO, March 25, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update demonstrating that the Company continues to deliver market share advances by focusing on the highest revenue generating dried flower, pre-roll, and vape product categories. Consumers... Read more
Ryan Allway March 25th, 2022 News, Top News Construction begins on a new state-of-the-art manufacturing facility at Kent Science Park designed to support the manufacture of regulatory approved cannabis-based medicines This represents a significant commitment to the UK by GW Pharmaceuticals, now part of Jazz Pharmaceuticals, investing $100 million (£75m) and... Read more
